These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 16394481

  • 21. Histoid leprosy: case report.
    Bakry OA, Attia AM.
    Acta Dermatovenerol Croat; 2012; 20(4):256-9. PubMed ID: 23317487
    [Abstract] [Full Text] [Related]

  • 22. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV, Bulchand HO, Revankar CR, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract] [Full Text] [Related]

  • 23. [Correlation between dose/plasma concentration and assessment of hepatic and renal changes in Wistar rats treated with the ROM scheme].
    Malfará WR, Uyemura SA, Queiroz RH.
    Rev Soc Bras Med Trop; 2005 Sep; 38(2):167-72. PubMed ID: 15821793
    [Abstract] [Full Text] [Related]

  • 24. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
    2-3 Lesion Multicentre Trial Group.
    Indian J Lepr; 2001 Sep; 73(2):131-43. PubMed ID: 11579649
    [Abstract] [Full Text] [Related]

  • 25. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R, Revankar CR, Pai VV, Kingsley S.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract] [Full Text] [Related]

  • 26. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR, Pai VV, Samy MS, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract] [Full Text] [Related]

  • 27. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
    Lockwood DN, Cunha Mda G.
    Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
    [No Abstract] [Full Text] [Related]

  • 28. Multibacillary leprosy: follow up observations on 19 patients treated with 12 monthly doses of rifampicin, ofloxacin and minocycline therapy in Agra.
    Kumar A, Girdhar BK.
    Indian J Dermatol Venereol Leprol; 2014 Sep; 80(2):156-9. PubMed ID: 24685858
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
    Manickam P, Nagaraju B, Selvaraj V, Balasubramanyam S, Mahalingam VN, Mehendale SM, Pannikar VK, Gupte MD, Team of Study Investigators.
    Indian J Lepr; 2012 Sep; 84(3):195-207. PubMed ID: 23484334
    [Abstract] [Full Text] [Related]

  • 30. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Porichha D.
    Indian J Lepr; 1998 Sep; 70(2):213-4; author reply 219-21. PubMed ID: 9724858
    [No Abstract] [Full Text] [Related]

  • 31. [Long-term follow-up of ofloxacin-combined therapy for leprosy patients].
    Ozaki M, Ishikawa M.
    Nihon Hansenbyo Gakkai Zasshi; 2007 Sep; 76(3):207-18. PubMed ID: 17877033
    [Abstract] [Full Text] [Related]

  • 32. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S, Reddy R.
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract] [Full Text] [Related]

  • 33. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
    Pattyn S, Grillone S.
    Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986
    [No Abstract] [Full Text] [Related]

  • 34. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
    Ji B, Sow S, Perani E, Lienhardt C, Diderot V, Grosset J.
    Antimicrob Agents Chemother; 1998 May; 42(5):1115-20. PubMed ID: 9593137
    [Abstract] [Full Text] [Related]

  • 35. JAAD Grand Rounds. Posttreatment lesional hyperpigmentation.
    Mudigonda P, Ragland HP, Murina A.
    J Am Acad Dermatol; 2013 May; 68(5):879-81. PubMed ID: 23602180
    [No Abstract] [Full Text] [Related]

  • 36. Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy.
    Ji B, Grosset J.
    Lepr Rev; 2000 Dec; 71 Suppl():S81-7. PubMed ID: 11201894
    [Abstract] [Full Text] [Related]

  • 37. [High prevalence of leprosy in the Federated States of Micronesia and special project for the elimination].
    Matsuoka M.
    Nihon Hansenbyo Gakkai Zasshi; 1997 Nov; 66(3):199-205. PubMed ID: 9513345
    [Abstract] [Full Text] [Related]

  • 38. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL, Stefani MM, Pereira GA, Costa MB, Rebello PF, Gomes MK, Narahashi K, Gillis TP, Krahenbuhl JL, Martelli CM.
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [Abstract] [Full Text] [Related]

  • 39. Leprosy. Recognition and treatment.
    Ramos-e-Silva M, Rebello PF.
    Am J Clin Dermatol; 2001 Nov; 2(4):203-11. PubMed ID: 11705247
    [Abstract] [Full Text] [Related]

  • 40. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A, Girdhar A, Girdhar BK.
    Indian J Dermatol Venereol Leprol; 2015 Nov; 81(4):356-62. PubMed ID: 26144850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.